A detailed history of Groupama Asset Managment transactions in Argenx Se stock. As of the latest transaction made, Groupama Asset Managment holds 8,937 shares of ARGX stock, worth $5.33 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,937
Previous 6,091 46.72%
Holding current value
$5.33 Million
Previous $2.67 Billion 45.78%
% of portfolio
0.1%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$434.22 - $551.9 $1.24 Million - $1.57 Million
2,846 Added 46.72%
8,937 $3.89 Billion
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $1.71 Million - $2.17 Million
4,800 Added 371.8%
6,091 $2.67 Billion
Q1 2024

May 14, 2024

BUY
$356.95 - $413.29 $460,822 - $533,557
1,291 New
1,291 $2.58 Billion

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $33B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.